Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

Top 2 search results for "Brukinsa" in Resources. To see all results and access other features, sign up for free.

... The BTK inhibitors currently used are: Acalabrutinib (Calquence) Ibrutinib (Imbruvica) Pirtobrutinib (Jaypirca) Zanubrutinib (Brukinsa) BCL-2 InhibitorVenetoclax (Venclexta) is used to treat some cases of AML and CLL/SLL. ...
8 Leukemia Treatment Options You Should Know
... The BTK inhibitors currently used are: Acalabrutinib (Calquence) Ibrutinib (Imbruvica) Pirtobrutinib (Jaypirca) Zanubrutinib (Brukinsa) BCL-2 InhibitorVenetoclax (Venclexta) is used to treat some cases of AML and CLL/SLL. ...
... Targeted therapies used to treat CLL include: Bruton’s tyrosine kinase inhibitors, including Brukinsa (zanubrutinib), Calquence (acalabrutinib), and Imbruvica (ibrutinib) Phosphoinositide 3-kinase inhibitors, including Copiktra (duvelisib) and Zydelig (idelalisib) The B-cell lymphoma 2 inhibitor Venclexta (venetoclax) Monoclonal antibodies are another ...
Chronic Lymphocytic Leukemia Treatment Options
... Targeted therapies used to treat CLL include: Bruton’s tyrosine kinase inhibitors, including Brukinsa (zanubrutinib), Calquence (acalabrutinib), and Imbruvica (ibrutinib) Phosphoinositide 3-kinase inhibitors, including Copiktra (duvelisib) and Zydelig (idelalisib) The B-cell lymphoma 2 inhibitor Venclexta (venetoclax) Monoclonal antibodies are another ...